SOLUBLE UNCLOTTABLE COMPLEXES FORMED IN PRESENCE OF FIBRINOGEN DEGRADATION PRODUCTS (FDP) DURING FIBRINOGEN-FIBRIN CONVERSION AND THEIR POTENTIAL SIGNIFICANCE IN PATHOLOGY

被引：167

作者：

LIPINSKI, B

WEGRZYNO.Z

BUDZYNSK.AZ

KOPEC, M

LATALLO, ZS

KOWALSKI, E

机构：

来源：

THROMBOSIS ET DIATHESIS HAEMORRHAGICA | 1967年 / 17卷 / 1-2期

关键词：

D O I：

10.1055/s-0038-1654112

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：65 / +

页数：1

共 37 条

[11] PATHOGENESIS OF COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (FIBRINOLYTIC) STATES .1. SIGNIFICANCE OF FIBRINOGEN PROTEOLYSIS AND CIRCULATING FIBRINOGEN BREAKDOWN PRODUCTS
FLETCHER, AP
SHERRY, S
ALKJAERSIG, N
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1962, 41 (04) : 896 - &
[12] EFFECT OF FIBRIN AND FIBRINOGEN PROTEOLYSIS PRODUCTS ON CLOT PHYSICAL PROPERTIES
HIRSH, J
FLETCHER, AP
SHERRY, S
[J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1965, 209 (02): : 415 - &
[13] JERUSHALMY Z, 77 INF EXCH GROUP
[14] CRYOFIBRINOGENEMIA
KALBFLEISCH, JM
BIRD, RM
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1960, 263 (18) : 881 - 886
[15] KEKWICK RA, 1955, BIOCHEM J, V60, P671
[16] KESSEL KJ, 1960, VERH DEUTSCH GES INN, V66, P732
[17] KOLLER F, 1961, THROMBOS DIATH S1 ED, V6, P166
[18] KOPEC M, 1960, THROMB DIATH HAEMOST, V5, P285
[19] KOPEC M, IN PRESS
[20] KORST DR, 1955, NO TITLE, V10, P945